Background Opioid agonist therapy (OAT) has been shown to reduce opioid use and related
harms. However, many young people are not accessing OAT. This study sought to explore …

Background The COVID-19 pandemic has shifted mental health care delivery to digital
platforms, videoconferencing, and other mobile communications. However, existing reviews of …

… Andreas Pilarinos wrote this manuscript with significant support from Dr. Kora DeBeck and
Dr. Jane Buxton, who guided the conceptualization of the analyses, interpretation of results, …

Introduction Limited research examines buprenorphine-naloxone interest among adolescents
and young adults (AYA). This longitudinal study examined factors associated with initial …

Background and Aims Many people who use drugs (PWUD) are coerced into receiving
treatment. This study aimed to assess changes in substance use and related outcomes before …

Background A mounting body of evidence suggests that polysubstance use (PSU) is common
among people who use opioids (PWUO). Measuring PSU, however, is statistically and …

Importance The ongoing overdose crisis continues to adversely affect adolescents and young
adults (AYAs) and has led to numerous preventable deaths. Medications for opioid use …

Objective Retaining adolescents and young adults (AYA) in medications for opioid use disorder
(MOUD), like methadone maintenance treatment (MMT), is critical to reducing toxic drug …

Background: In Canada, Indigenous Peoples continue to experience persistent health
inequities, resulting in disproportionately poorer health outcomes compared with non-Indigenous …

We thank Clark and colleagues for their presentation of an ethical perspective on secure care
in response to our previously published commentary on this topic (1, 2). We fully agree that …